ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1376 • ACR Convergence 2023

    SJOGRENSER Registry: Prospective Evaluation of a Cohort of Patients with Primary Sjögren’s Syndrome After 8 Years of Follow-up

    Mónica Fernández-Castro1, Zulema Plaza2, Jose Rosas3, Victor Martinez-Taboada4, Alejandro Olivé5, Raúl Menor-Almagro6, SARA MANRIQUE7, Ruth López-González8, Celia Erausquin9, Antonio Naranjo9, Rocío Caño-Alameda10, Silvia Gómez-Sabater10, Jesús Alberto García Vadillo11, Belen Serrano Benavente12, Sheila Melchor13, Paula V. Estrada-Alarcón14, Angel Garcia-Aparicio15, Cristina Bohorquez16, Enrique Júdez17, Ximena Larco18, Javier Loricera19, Nerea Alcorta Lorenzo20, Beatriz Paredes Romero21, Jorge González Martín22, María Ángeles Blázquez Cañamero23, Consuelo Ramos-Giráldez24, Fernando Alonso25, Marta Domínguez26 and Jose Luis Andreu-Sánchez27, 1Rheumatology Department Hospital Puerta de Hierro Majadahonda, Majadahonda, Spain, 2Universidad Autónoma de Madrid, Madrid, Spain, 3Hospital Marina Baixa, Alicante, Spain, 4Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain, 5Rheumatology Department Hospital Germans Trias i Pujol, Badalona, Spain, 6Rheumatology, Hospital Jerez, Puerto De Santa María, Spain, 7Division of Rheumatology, Hospital Regional Universitario Carlos Haya, Malaga, Spain, 8Rheumatology Department Hospital Virgen de la Concha, Zamora, Spain, 9Rheumatology Department Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain, 10Rheumatology Department, Dr. Balmis University General Hospital, Alicante. Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain, 11Rheumatology Department Hospital de la Princesa, Madrid, Spain, 12Rheumatology Department Hospital Gregorio Marañón, Madrid, Spain, 13Rheumatology Department Hospital Doce de Octubre, Madrid, Spain, 14Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 15Hospital Universitario de Toledo, Toledo, Spain, 16Rheumatology Unit, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain, 17Rheumatology Department Hospital de Albacete, Albacete, Spain, 18Rheumatology Department Hospital de León, León, Spain, 19Hospital Universitario Marqués de Valdecilla, Santander, Spain, 20University Hospital Donostia, San Sebastian, Spain, 21Rheumatology Department Hospital Infanta Sofía, San Sebastian de los Reyes, Spain, 22Rheumatology Department Hospital Madrid Norte Sanchinarro, Madrid, Spain, 23Rheumatology Department Hospital Ramon y Cajal, Madrid, Spain, 24Rheumatology Department Hospital Universitario Virgen de Valme, Sevilla, Spain, 25Spanish Society of Rheumatology, Madrid, Spain, 26Sociedad Española de Reumatología, Madrid, Spain, 27Rheumatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain

    Background/Purpose: Describe the evolution of patients with Sjögren's syndrome (SS) in relation to the appearance of new systemic manifestations and disease activity, as well as…
  • Abstract Number: 1350 • ACR Convergence 2023

    Identification of ACR Guidelines for SLE Pregnancy Care in the Electronic Health Record

    Noah Forrest1, Joshua Waytz2, April Barnado3, Megan Clowse4, Theresa Walunas1 and Rosalind Ramsey-Goldman5, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern Medicine, Chicago, IL, 3Vanderbilt University Medical Center, Nashville, TN, 4Duke University, Chapel Hill, NC, 5Northwestern University, Chicago, IL

    Background/Purpose: SLE is an autoimmune disease with an increased risk for poor outcomes in pregnancy. In 2020, ACR specified several recommendations to assist clinicians in…
  • Abstract Number: 1366 • ACR Convergence 2023

    A Unique Cluster of Inflammatory Monocytes and Functionally Intact Regulatory T Cells in Rare Childhood Sjögren’s Disease

    Myung-Chul Kim1, Umasankar De2, Nicholas Borcherding3, Joon Paek4, Nicole Winn5, Indraneel Bhattacharyya6, Qing Yu7, Ryan Kolb8, Theodore Drashansky9, Akaluck Thatayatikom10, Weizhou Zhang8 and Seunghee Cha11, 1Jeju National University, Jeju-si, South Korea, 2University of Florida, Gainesville, FL, 3Washington University School of Medicine in St. Louis, Washington, DC, 4Department of Oral & Maxillofacial Diagnostic Sciences, Gainesville, FL, 5Division of Oral Medicine, Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, 6Department of Oral & Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, 7The Forsyth Institute, Cambridge, MA, 8Department of Pathology & Immunology, University of Florida, Gainesville, FL, 9Cellularity, Inc, Florham Park, NJ, 10AdventHealth for Children, Orlando, FL, Orlando, FL, 11Department of Oral & Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry and Center for Orphaned Autoimmune Disorders (COAD), Gainesville, FL

    Background/Purpose: This study was performed to characterize key immune cell subsets and their interactions in patients with childhood Sjögren's disease (cSjD) for the first time…
  • Abstract Number: 1387 • ACR Convergence 2023

    Power Doppler Musculoskeletal Abnormalities in Patients with Psoriasis at High Risk of Progression to Psoriatic Arthritis

    Rebecca Haberman1, Sarah Moussavi1, Yan Zhang1, Sydney Catron1, Jonathan Samuels2, Rebecca Blank3, Michael Toprover4, Jiyuan Hu1, Cinty Gong5, Vincent Piguet6, Francisco Tausk7, Jensen Yeung8, Andrea Neimann1, Wayne Gulliver9, Joseph Merola10, Alexis R Ogdie11, Proton Rahman12, Soumya Chakravarty13, Ralf Thiele14, Lihi Eder15, Christopher T Ritchlin16 and Jose Scher17, 1NYU Grossman School of Medicine, New York, NY, 2NYU Langone, Rye Brook, NY, 3New York University, New York, NY, 4New York University Langone Health, New York, NY, 5Immunology, Janssen Scientific Affairs, LLC, Horsham, PA, USA, Raritan, NJ, 6Women's College Hospital, Toronto, ON, Canada, 7University of Rochester Medical Center, Rochester, NY, 8University of Toronto and Women’s College Hospital, Toronto, ON, Canada, 9Memorial University of Newfoundland, St. John's, NL, Canada, 10Harvard Medical School, Brigham and Women's Hospital, Newton, MA, 11University of Pennsylvania, Philadelphia, PA, 12Craig Dobbin Research Institute, Memorial University, St. John's, NL, Canada, 13Immunology, Janssen Scientific Affairs, LLC / Division of Rheumatology, Drexel University College of Medicine, Villanova, PA, 14University of Rochester, Pittsford, NY, 15Women’s College Research Institute, Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 16University of Rochester Medical School, Allergy, Immunology & Rheumatology Division, Canandaigua, NY, 17New York University School of Medicine, New York, NY

    Background/Purpose: Psoriatic arthritis (PsA) is an immune-mediated disease associated with skin psoriasis that, if untreated, can lead to joint destruction. Up to 30% of patients…
  • Abstract Number: 1389 • ACR Convergence 2023

    Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis

    raquel granados1, Santiago Dans-Caballero1, Lourdes Ladehesa Pineda2, María Ángeles Puche Larrubia3, Desiree Ruiz Vilchez4, Maria del Carmen Abalos-Aguilera4, Alejandro Escudero-Contreras5, Eduardo Collantes Estévez6 and Clementina López Medina7, 1Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain, 2Rheumatology Department Reina Sofia Universitary Hospital, Cordoba, Spain, 3Department of Rheumatology, Reina Sofia University Hospital, Cordoba, Spain, 4Rheumatology Department, Reina Sofia University Hospital/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain, 5Rheumatology Department, Reina Sofia University Hospital, Cordoba/Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Córdoba, Spain, 6Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Cordoba, Spain, 7Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris; Rheumatology Department, Reina Sofia Hospital, Cordoba / IMIBIC / University of Cordoba, Cordoba, Spain

    Background/Purpose: Axial spondyloarthritis (axSpA) is characterized by progressive structural damage on the sacroiliac joints and/or the spine. Conventional radiology allows to assess radiology through available…
  • Abstract Number: 1369 • ACR Convergence 2023

    Treatment Patterns and Drivers of Biologic Prescriptions in Patients with Primary Sjögren’s Disease: Results from a Multinational, Real-World Survey

    Sara McCoy1, Alan Baer2, Ann Xi3, Giorgio Castellano4, Victoria Barton4, Anthony Amatucci5, Ilias Alevizos6 and Haridarshan Patel7, 1University of Wisconsin School of Medicine and Public Health, Middleton, WI, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Horizon Therapeutics, Indianapolis, IN, 4Adelphi Real World, Bollington, United Kingdom, 5Horizon Therapeutics, Cambridge, MA, 6Horizon Therapeutics, Rockville, MD, 7Horizon Therapeutics, Deerfield, IL

    Background/Purpose: Currently, no systemic therapies have been approved for Sjögren's disease (SjD) due to limited evidence regarding efficacy. However, biologics are often used in patients…
  • Abstract Number: 1384 • ACR Convergence 2023

    Functional Status by Sex and Socioeconomic Status in Axial Spondyloarthritis

    Rachael Stovall1, Jing Li1, zara izadi1, Lianne Gensler2, Gabriela Schmajuk3 and Jinoos Yazdany4, 1University of California San Francisco, San Francisco, CA, 2University of California San Francisco, Department of Medicine, Division of Rheumatology, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA, 4University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

    Background/Purpose: Women with axial spondyloarthritis (axSpA) tend to have worse patient reported outcomes compared to men. Non-U.S. studies have evaluated functional status (FS) by sex…
  • Abstract Number: 1380 • ACR Convergence 2023

    Synergistic Dose Effects of Extra X Chromosome in Development of Sjogren’s Syndrome in Klinefelter and Triple X Syndromes

    Anna-Kay Palmer1 and Irene Tan2, 1Albert Einstein Medical Center, Philadelphia, PA, 2Einstein Medical Center Philadelphia, Bala Cynwyd, PA

    Background/Purpose: Immune-related genes located on the X chromosome are known to be important in the regulation of sex hormones and immune tolerance. It has been…
  • Abstract Number: 1392 • ACR Convergence 2023

    Improving the Diagnostic Accuracy in Axial Spondyloarthritis: Interim Results of a Nationwide Telemedicine Project

    Denis Poddubnyy1, Marc Kämmerer2, Marcus Kremers3, Berit Schoppen3, Charlotte Arens3, Annette Wiedon4, Imke Redeker5 and Xenofon Baraliakos6, 1Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2VISUS Health IT GmbH, Bochum, Germany, 3MedEcon Telemedizin GmbH / MedEcon Ruhr GmbH, Bochum, Germany, 4Novartis Pharma GmbH, Nürnberg, Germany, 5Ruhr Universität Bochum, Bochum, Germany, 6Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is often diagnosed late, while there is also a problem of over- and misdiagnosis in patients with chronic back pain. Imaging,…
  • Abstract Number: 1381 • ACR Convergence 2023

    Fatigue and Associated Factors in Patients with Primary Sjogren’s Syndrome Compared to Secondary Sjogren’s Syndrome

    Hyeji Jeon, Hyun-Sook Kim and Kyung-Ann Lee, Soonchunhyang University Seoul Hospital, Seoul, South Korea

    Background/Purpose: Fatigue is one of the dominant symptoms of patients with Primary Sjogren's syndrome (pSS). However, whether fatigue is specific to pSS compared to secondary…
  • Abstract Number: 1368 • ACR Convergence 2023

    Development of the Sjögren’s-related Quality of Life (SRQoL) to Assess Health-related Quality of Life (HRQoL) in Sjögren’s

    Benjamin A Fisher1, Linda Stone2, Jessica Marvel3, Pushpendra Goswami4, Monia Steenackers4, Gayle Kenney4, Chiara Perella5, Wolfgang Hueber4, Chloe Howse6, Elizabeth Gargon6, Aishwarya Chohan6, Megan Mayhew6 and Nicola Williamson6, 1University of Birmingham, Birmingham, United Kingdom, 2The British Sjogren’s Syndrome Association, Birmingham, United Kingdom, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Novartis Pharma AG, Basel, Switzerland, 5Novartis Pharma AG, Riehen, Switzerland, 6Adelphi Values Patient-Centered Outcomes, Bollington, United Kingdom

    Background/Purpose: Sjögren's is a heterogenous chronic auto-immune disease, characterized by excessive dryness of the eyes and mouth, as well as systemic complications which can significantly…
  • Abstract Number: 1339 • ACR Convergence 2023

    Neutrophil Activation and Formation of Neutrophil Extracellular Traps Are Associated with Response to Abatacept in Patients with Moderate to Severe Rheumatoid Arthritis

    Ting Wang1, Natalia V. Giltiay2, Christian Lood2 and Bobby Kwanghoon Han2, 1University of Washington, Seattle, WA, 2Division of Rheumatology, University of Washington, Seattle, WA

    Background/Purpose: Neutrophil activation and formation of neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of rheumatoid arthritis (RA). Calprotectin, a neutrophil activation marker,…
  • Abstract Number: 1373 • ACR Convergence 2023

    Deltex1 May Involve the Function of T Regulatory Cells and Regulate the Disease Activity of Sjögren’s Syndrome

    Ming-Han Chen, Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    Background/Purpose: Deltex1 is a transcription target of nuclear factor of activated T cells in mice and promotes T cell anergy. We have previously reported that…
  • Abstract Number: 1335 • ACR Convergence 2023

    Effectiveness of Longstanding Exercise Therapy versus Usual Care in People with Rheumatoid Arthritis and Severe Functional Limitations: A Randomized Controlled Trial (L-EXTRA)

    Max Teuwen1, Salima van Weely1, Thea Vliet Vlieland2, Manja van Wissen1, Wilfred Peter1, Alfons den Broeder3, Dirkjan van Schaardenburg4, Wilbert van den Hout1, Cornelia van den Ende3 and Maaike gademan1, 1Leiden University Medical Center, Leiden, Netherlands, 2Leids University Medical Center, Leiden, Netherlands, 3Sint Maartenskliniek, Nijmegen, Netherlands, 4Reade, Amsterdam, Netherlands

    Background/Purpose: Supervised exercise therapy is an effective and safe treatment option for people with rheumatoid arthritis (RA). However, most studies involve interventions of relatively short…
  • Abstract Number: 1353 • ACR Convergence 2023

    Sexual Dysfunction in Women with Systemic Lupus Erythematosus: A Cross-Sectional Multicentre Study

    Maria Helena Lourenco1, Rita Torres2, Santiago Rodrigues-Manica3, Vanessa Fraga4, Ana Catarina Abreu5, Roberto Costa6, Carolina Ochôa Matos7, Beatriz Mendes8, Beatriz Samões9, Inês Silva1, Fernando Pimentel-Santos10, Manuela Costa1, Jaime Branco11 and Alexandre Sepriano12, 1Hospital Egas Moniz, Lisbon, Portugal, 2Hospital Egas Moniz, Lisboa, Portugal, 3Hospital Egas Moniz, CHLO, Lisboa, Portugal, 4Hospital Garcia de Orta, Nogueira da Regedoura, Portugal, 5Hospital Garcia de Orta, Lisboa, Portugal, 6Centro Hospitalar Lisboa Norte, Lisboa, Portugal, 7Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 8Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 9Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal, 10NOVA Medical School; Universidade NOVA e Lisboa, Lisboa, Portugal, 11CHLO, EPE - Hospital Egas Moniz, Lisbon, Portugal, 12Leiden University Medical Centre, Portela Loures, Portugal

    Background/Purpose: Due to its multisystemic involvement, systemic lupus erythematosus (SLE) can have a significant impact on patients' quality of life (QoL). Sexual (dis)function is a…
  • « Previous Page
  • 1
  • …
  • 386
  • 387
  • 388
  • 389
  • 390
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology